Tag Archives: Dilated Cardiomyopathy Therapeutics Market Size

Dilated Cardiomyopathy Therapeutics Market Size, Competitive Analysis, Share, Forecast- 2020-2026

The global dilated cardiomyopathy (DCM) therapeutics market is anticipated to grow with a significant CAGR of 8% during the forecast period. DCM is one of the prevalent causes of heart failure in adult patients and represents the most common diagnosis leading to a heart transplant in children. The advancements in healthcare and the introduction of […]